9 Patents
- US123369882025Therapeutic Targeting of KMT2D Mutant Lung Squamous Cell Carcinoma Through RTK-RAS Signaling Inhibition
NEW YORK UNIVERSITY
0 cites - 0 cites
- US121152542024Methods of Use of Emulsion Formulations of an NK-1 Receptor Antagonist
Heron Therapeutics, Inc.
0 cites - US121152552024Methods of Use of Emulsion Formulations of an NK-1 Receptor Antagonist
HERON THERAPEUTICS, Inc.
0 cites - US118780742024Methods of Use of Emulsion Formulations of an NK-1 Receptor Antagonist
Heron Therapeutics, Inc.
0 cites - US117448002023Methods of Use of Emulsion Formulations of an NK-1 Receptor Antagonist
HERON THERAPEUTICS, Inc.
0 cites - US117171042023Spiral Blade, Grinding Component and Food Processor0 cites
- US117177982023Food Processor0 cites
- 0 cites